News & Resources
Recent Posts
Decode Health Expands Strategic Advisory Board
New members bring cross-industry insights to the company Nashville, Tenn. – Nov. 11, 2020 – Chase Spurlock, PhD, founder and CEO [read more...]
Local Startup Develops AI Platform for Predicting COVID-19 Trends
One-year-old technology startup Decode Health has developed a predictive artificial intelligence platform that identifies emerging trends in the COVID-19 outbreak, providing governments and other organizations early insights to where resources need to be allocated to provide targeted outreach among high-risk populations.
Decode Health Launches Eight-Person Strategic Advisory Board Chaired by Dr. Alan Spiro
Board members advise on applications of the company’s AI solution and strategic partnerships
As Seen In
Podcasts
Publications
News
Data Analytics Holds Promise of Dramatically Improving Outcomes for Patients with Autoimmune Disease.
The movement to embrace predictive analytics, which has been gathering steam over the past several years, will be especially important as hospitals seek to improve their capabilities to forecast, detect and monitor chronic conditions, especially autoimmune diseases. Read the Article
Predictive Analytics: How Big Data Will Improve Outcomes and Efficiencies in Diagnosing and Treating Patients
A growing body of research in the exciting field of predictive and prescriptive analytics suggests that if you input large datasets—drawn from millions of healthcare claims or electronic medical records, for example—sophisticated algorithms can identify patterns that deliver meaningful diagnostic information for patients with a wide range of conditions. These [read more...]
MS & AI with Dr. Chase Spurlock, CEO of IQuity
Artificial intelligence is changing healthcare. And that might include how MS will be diagnosed, treated, and managed. It's even beginning to impact the way some MS research is being conducted. Chase Spurlock, PhD, founder and CEO of IQuity talks about how IQuity is using its expertise in machine learning to [read more...]
Blog
Addressing the Emergent Issue of Long COVID
Although COVID-19 hospitalizations and death rates have dominated the media, another challenge has quietly emerged during the pandemic. Some COVID patients are reporting a wide variety of debilitating symptoms, often lasting months after being diagnosed. Commonly referred to as long COVID, scientists are just beginning to understand the long-term [read more...]
Illuminating an Invisible Epidemic: Addressing Cost Drivers in Diagnosis and Treatment of Autoimmune Diseases and Disorders
Everyone knows at least one person with an autoimmune disease or disorder and just may not know it. Even if you think you don’t, you most likely do, considering autoimmune diseases affect approximately 50 million Americans while cancer affects 15 million. Both diseases substantially impact society, but how do we [read more...]